These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

592 related articles for article (PubMed ID: 22721581)

  • 1. Type 2 diabetes after gastric bypass: remission in five models using HbA1c, fasting blood glucose, and medication status.
    Blackstone R; Bunt JC; Cortés MC; Sugerman HJ
    Surg Obes Relat Dis; 2012; 8(5):548-55. PubMed ID: 22721581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative fasting plasma C-peptide level may help to predict diabetes outcome after gastric bypass surgery.
    Aarts EO; Janssen J; Janssen IM; Berends FJ; Telting D; de Boer H
    Obes Surg; 2013 Jul; 23(7):867-73. PubMed ID: 23475775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Predictors of Type 2 Diabetes Mellitus Remission After Roux-en-Y Gastric Bypass in 101 Chinese Patients.
    Yan W; Bai R; Li Y; Xu J; Zhong Z; Xing Y; Yan M; Lin Y; Song M
    Obes Surg; 2019 Jun; 29(6):1867-1873. PubMed ID: 30798440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes in glycemic control in the intermediate follow-up of Roux-en-Y gastric bypass: a Brazilian cohort study.
    Beleigoli AM; Coelho AL; Diniz MT; Lages Savassi-Rocha A; Diniz Mde F
    Surg Obes Relat Dis; 2014; 10(6):1022-7. PubMed ID: 25445150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of diabetes remission after bariatic surgery may be jeopardized by remission criteria and previous hypoglycemic treatment.
    Ramos-Levi A; Sanchez-Pernaute A; Matia P; Cabrerizo L; Barabash A; Hernandez C; Calle-Pascual A; Torres A; Rubio M
    Obes Surg; 2013 Oct; 23(10):1520-6. PubMed ID: 23702908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obese Patients with Type 2 Diabetes: Outcomes After Laparoscopic Sleeve Gastrectomy.
    Viscido G; Gorodner V; Signorini FJ; Biasoni AC; Navarro L; Rubin G; Obeide L; Moser F
    J Laparoendosc Adv Surg Tech A; 2019 May; 29(5):655-662. PubMed ID: 30452318
    [No Abstract]   [Full Text] [Related]  

  • 7. "Dual-remission" after Roux-en-Y gastric bypass surgery: Glycemic variability cannot always be improved in Chinese obese patients with type 2 diabetes.
    Yu H; Zhou J; Bao Y; Pin Zhang ; Lu W; Jia W
    Surg Obes Relat Dis; 2016 Aug; 12(7):1312-1319. PubMed ID: 26823091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of type 2 diabetes relapse after Roux-en-Y Gastric Bypass: A ten-year follow-up study.
    Moriconi D; Manca ML; Anselmino M; Rebelos E; Bellini R; Taddei S; Ferrannini E; Nannipieri M
    Diabetes Metab; 2022 Jan; 48(1):101282. PubMed ID: 34547450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative factors predicting remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery for obesity.
    Hall TC; Pellen MG; Sedman PC; Jain PK
    Obes Surg; 2010 Sep; 20(9):1245-50. PubMed ID: 20524158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effects of laparoscopic Roux-en-Y gastric bypass on diabetes mellitus, hypertension and dyslipidaemia in morbidly obese patients.
    Dogan K; Betzel B; Homan J; Aarts EO; Ploeger N; de Boer H; Aufenacker TJ; van Laarhoven CJ; Janssen IM; Berends FJ
    Obes Surg; 2014 Nov; 24(11):1835-42. PubMed ID: 25027982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of roux-en Y gastric bypass surgery on prognostic factors of type 2 diabetes mellitus: meta-analysis and systematic review.
    Chen Y; Zeng G; Tan J; Tang J; Ma J; Rao B
    Diabetes Metab Res Rev; 2015 Oct; 31(7):653-62. PubMed ID: 25387821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuated improvements in adiponectin and fat loss characterize type 2 diabetes non-remission status after bariatric surgery.
    Malin SK; Bena J; Abood B; Pothier CE; Bhatt DL; Nissen S; Brethauer SA; Schauer PR; Kirwan JP; Kashyap SR
    Diabetes Obes Metab; 2014 Dec; 16(12):1230-8. PubMed ID: 25132119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remission of type 2 diabetes mellitus should not be the foremost goal after bariatric surgery.
    Ramos-Levi AM; Sanchez-Pernaute A; Cabrerizo L; Matia P; Barabash A; Hernandez C; Calle-Pascual AL; Torres AJ; Rubio MA
    Obes Surg; 2013 Dec; 23(12):2020-5. PubMed ID: 23893315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type 2 diabetes remission after Roux-en-Y gastric bypass (RYGB), sleeve gastrectomy (SG), and one anastomosis gastric bypass (OAGB): results of the longitudinal assessment of bariatric surgery study.
    Moradi M; Kabir A; Khalili D; Lakeh MM; Dodaran MS; Pazouki A; Kermansaravi M; Alibeigi P; Moazenzadeh H; Abdolhosseini MR; Eghbali F; Baradaran HR
    BMC Endocr Disord; 2022 Oct; 22(1):260. PubMed ID: 36289529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remission of type 2 diabetes after Roux-en-Y gastric bypass is associated with greater weight loss.
    Kadera BE; Lum K; Grant J; Pryor AD; Portenier DD; DeMaria EJ
    Surg Obes Relat Dis; 2009; 5(3):305-9. PubMed ID: 19460674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five-Year-Results of Laparoscopic Sleeve Gastrectomy with Duodenojejunal Bypass for Weight Loss and Type 2 Diabetes Mellitus.
    Seki Y; Kasama K; Haruta H; Watanabe A; Yokoyama R; Porciuncula JP; Umezawa A; Kurokawa Y
    Obes Surg; 2017 Mar; 27(3):795-801. PubMed ID: 27644433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships between type 2 diabetes remission after gastric bypass and different weight loss metrics: arguments against excess weight loss in metabolic surgery.
    van de Laar AW; de Brauw LM; Meesters EW
    Surg Obes Relat Dis; 2016 Feb; 12(2):274-82. PubMed ID: 26476492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case-matched outcomes in bariatric surgery for treatment of type 2 diabetes in the morbidly obese patient.
    Dorman RB; Serrot FJ; Miller CJ; Slusarek BM; Sampson BK; Buchwald H; Leslie DB; Bantle JP; Ikramuddin S
    Ann Surg; 2012 Feb; 255(2):287-93. PubMed ID: 21975321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is Roux-en-Y gastric bypass surgery the most effective treatment for type 2 diabetes mellitus in morbidly obese patients?
    Torquati A; Lutfi R; Abumrad N; Richards WO
    J Gastrointest Surg; 2005 Nov; 9(8):1112-6; discussion 1117-8. PubMed ID: 16269382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic effects and safety of Roux-en-Y gastric bypass surgery vs. conventional medication in obese Chinese patients with type 2 diabetes.
    Feng W; Yin T; Chu X; Shan X; Jiang C; Wang Y; Qian Y; Zhu D; Sun X; Bi Y
    Diabetes Metab Res Rev; 2019 Jul; 35(5):e3138. PubMed ID: 30740871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.